Company / Return on Assets (ROA)
Amgen Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
8.5%
FY2025
5-year range
4.5% / 12.8%
FY2021-FY2025
Trend
+91.2%
vs FY2024
Sector context
#30 of 213
Health Care
What the data says
Amgen's return on assets (roa) of 8.5% is higher than 86% of companies in the Health Care sector (FY2025). Return on Assets (ROA) returned to growth in FY2025 after 4 years of decline, reaching 8.5%.
Based on SEC 10-K filings.
8.5% in FY2025 with a 5-year CAGR of -4.8%. Top quartile in the Health Care sector.
Improved from 6.9% to 8.5% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -2.6pp
- 5-Year Change
- -4.8pp
- 10-Year Change
- -
Sector benchmark
Top 14% in Health CareTop 14% of 213This company 8.5% Sector average -24.1%
▼
+135.3% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 91.2% year-over-year.
- Currently 32.6pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.5% | +91.2% |
| FY2024 | 4.5% | -35.6% |
| FY2023 | 6.9% | -38.0% |
| FY2022 | 11.2% | -13.0% |
| FY2021 | 12.8% | -3.8% |
| FY2020 | 13.3% | +302.7% |
| FY2019 | 3.3% | -71.5% |
| FY2018 | 11.6% | +34.0% |
| FY2017 | 8.7% | +30.7% |
| FY2016 | 6.6% | -31.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026